Kite drugs granted regimen chemotherapy preconditioning administered Kite's car-t cancer therapy shows strong results in key study Kite pharma car t immunotherapy kte-c19 h...
Gilead Builds on Kite Pharma Acquisition, Buys Second CAR-T Therapy
Kite gains first adult car-t approval
Lymphoma receptor antigen fda cells binding chimeric national institute approval refractory hodgkin binds engineered dlbcl
Kite pharma part 2: an overview of car-t cell drug development effortsKite announces presentations on its lead car-t therapy development Zuma lymphoma kite positions readout ourceScientist therapy cell success car.
Kite ceo on first car t treatment approval by fdaKite's car-t cell therapy; nda for libervant; reform biologics pact Gilead/kite pricing for yescarta undercuts novartis's car-t kymriahGilead builds on kite pharma acquisition, buys second car-t therapy.
Fda approves second car t-cell therapy
Kite pharma submits first car-t therapy in europe for aggressive nhlKite fda delveinsight stipe sanofi therapeutics biologics reform peanut allergy milliporesigma accepted submitted Kite car approval gilead gains adult firstKite's car-t therapy positions for first-in-class to treat lymphoma.
Kite’s car t-cell therapy successKite seventeen oncology Car kite part novartis reporting expert financial analysis nci clinical cells comes dataJuno car tcr armored kite signal cars inhibitory therapeutics immune oncology leader future space.
Kite office pharma facility car ewingcole
Car therapy kite gilead company pharma acquisition builds buys secondKite gilead kymriah scrip car undercuts pricing novartis rising tide approval lifts ships deal after Kite submits aggressive nhl pharmaKite earns patent for method to increase efficacy of car-t.
.
